Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
暂无分享,去创建一个
A. Venkatakrishnan | G. Gores | J. Halamka | W. Kremers | E. Theel | A. Puranik | A. Badley | V. Soundararajan | J. O’Horo | W. Faubion | Amy W. Williams | W. Morice | M. Binnicker | D. Challener | C. Kirkup | V. Agarwal | A. Lopez-Marquez | A. Williams
[1] Gilbert GREUB,et al. Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples , 2020, Pathogens and disease.
[2] Eric Song,et al. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets , 2020, Nature Microbiology.
[3] C. Pawlowski,et al. Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures , 2020, medRxiv.
[4] Tomislav Bedeković,et al. Evaluation of Serological Tests for Detection of Antibodies against Lumpy Skin Disease Virus , 2020, Journal of Clinical Microbiology.
[5] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[6] J. Thachil,et al. Coagulation abnormalities and thrombosis in patients with COVID-19 , 2020, The Lancet Haematology.
[7] A. Phelan,et al. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges , 2020, The Lancet.
[8] D. Montefiori,et al. Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 , 2020, bioRxiv.
[9] E. Theel,et al. The Role of Antibody Testing for SARS-CoV-2: Is There One? , 2020, Journal of Clinical Microbiology.
[10] D. Raoult,et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[11] B. La Scola,et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[12] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[13] Zhenshun Cheng,et al. The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients , 2020, Journal of medical virology.
[14] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[15] M. C. Muenker,et al. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets , 2020, Nature Microbiology.
[16] Robert C. Walchak,et al. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing , 2020, Journal of Clinical Microbiology.
[17] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[18] H. Shan,et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples , 2020, The Lancet Gastroenterology & Hepatology.
[19] Eric H. Y. Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[20] Quanyi Wang,et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR , 2020, Talanta.
[21] Qi Zhao,et al. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 , 2020, International journal of biological sciences.
[22] K. Kim,et al. What Is COVID-19? , 2020, Frontiers for Young Minds.
[23] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[24] En-Ming Kang,et al. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 , 2020, Travel Medicine and Infectious Disease.
[25] Fang Liu,et al. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens , 2020, Emerging microbes & infections.
[26] D. Garcin,et al. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission , 2018, eLife.
[27] Jonathan J Deeks,et al. Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.
[28] Pei-Jer Chen,et al. Emerging hepatitis B virus infection in vaccinated populations: a rising concern? , 2012, Emerging Microbes & Infections.
[29] G. Bren,et al. Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells , 2010, PLoS pathogens.
[30] Eriko,et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .